Pfizergate: Belgian court postpones case to December taking pressure off von der Leyen on 20/05/24
On Friday, hearing before a Belgian court on the Pfizergate was postponed to 6 December to give all parties additional time to further examine certain aspects of the case, such as the competence conflict between the Belgian investigating judge and the EPPO. WHO warns of intensified antimicrobial resistance, updating priority pathogen list on 17/05/24
The EU’s Health Emergency Preparedness and Response Authority (HERA) welcomes publication of the updated World Health Organisation Bacterial Priority Pathogens List (WHO BPPL). EMA safety committee suspend medicine used to prevent premature birth on 17/05/24
The European Medicines Agency (EMA) suspended the use of the hydroxyprogesterone caproate medicines, which mimic progestin hormone, amid doubts about their medical benefits and concerns that they might be related to increased cancer risk. EU needs to catch up with US in research and development, lobby warns on 17/05/24
Les Entreprises du médicament en France (Leem), an association of French pharmaceutical companies, unveiled its manifesto on Friday (May 17) ahead of June's EU elections, with the focus on investing in research and development (R&D) to avoid falling behind the United States. Slovak Health Minister Dolinková survives no-confidence vote [Advocacy Lab Content] on 15/05/24
Slovakia is facing political turmoil focused on health minister, Zuzana Dolinková. She survived her first no-confidence vote on 14 May, after only seven months in office. The culture minister also faced recall in back-to-back votes. Health Commissioner Kyriakides: Discrimination against cancer survivors unacceptable on 15/05/24
As the clock ticks towards the end of the current Commission mandate, stakeholders gathered in Brussels (14 May) for a stocktaking on progress towards an agreement on an EU code of conduct for fair access to financial services for cancer survivors. Ireland’s clinical trials scorecard outpaced by Denmark, says biopharma trade body [Advocacy Lab Content] on 15/05/24
Ireland is attracting fewer clinical trials than some EU countries with similar populations and economic performances, according to a new report by the IPHA, Ireland's biopharmaceutical industry body. Denmark attracts almost three times as many industry clinical trials. Study reveals long diagnostic delays for rare diseases in Europe on 14/05/24
A recent European-wide patient survey study published in the European Journal of Human Genetics on Tuesday has uncovered significant delays in diagnosing rare diseases across the continent. French industry minister Lescure welcomes Italian pharma company Chiesi’s investment in France on 14/05/24
French delegate minister of Industry Roland Lescure visited the production site of Italian pharmaceutical group Chiesi in the Loir-et-Cher département on Tuesday (May 14), after the company announced an investment of €10 million. Hungary’s ageing health system suffering traumatic personnel loss [Advocacy Lab Content] on 14/05/24
The professional standards of Hungarian healthcare providers are under scrutiny following the introduction of a new framework of healthcare regulations. An ageing population is being cared for by an ageing medical workforce.
|
|
